Medexus Pharmaceuticals Inc. (TSX: MDP)

Medexus Pharmaceuticals Revenue

Medexus Pharmaceuticals had revenue of $115.73M USD in the twelve months ending December 31, 2023, with 16.04% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $25.21M USD, a -12.25% decrease year-over-year. In the fiscal year ending March 31, 2023, Medexus Pharmaceuticals had annual revenue of $108.10M USD with 40.93% growth.

• Revenue (ttm): $115.73M
• Revenue Growth: +16.04%
• P/S Ratio: 0.28
• Revenue / Employee: $1,411,280
• Employees: 82
• Market Cap: 44.51M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	108.10M	31.40M	40.93%
Mar 31, 2022	76.70M	-2.96M	-3.71%
Mar 31, 2021	79.66M	27.23M	51.93%
Mar 31, 2020	52.43M	27.07M	106.73%
Mar 31, 2019	25.36M	17.61M	227.23%
Mar 31, 2018	7.75M	3.10M	66.52%
Mar 31, 2017	4.65M	1.77M	61.10%
Mar 31, 2016	2.89M	-803.68K	-21.76%
Mar 31, 2015	3.69M	624.15K	20.34%
Mar 31, 2014	3.07M	-	-